A Phase 2, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of Intravenous Ulimorelin (LP101) in Patients With Enteral Feeding Intolerance (EFI)
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2018
At a glance
- Drugs Ulimorelin (Primary) ; Metoclopramide
- Indications Digestive system disorders
- Focus Therapeutic Use
- Acronyms PROMOTE
- Sponsors Lyric Pharmaceuticals
- 17 Jan 2018 According to a Lyric Pharmaceuticals media release, data from this trial are expected in mid-2018.
- 21 Jul 2016 Status changed from not yet recruiting to recruiting.
- 03 Jun 2016 New trial record